.jpg?format=webp&width=780)
This study identified 28 studies for inclusion: 13 randomized and 15 non‐randomized. Most targeted surveillance/management of physical effects (n = 24), including 13 also targeted psychosocial outcomes. Four studies addressed prevention/surveillance for recurrence/new cancers, one addressed health promotion/disease prevention, and one addressed chronic medical conditions. Most studies (n = 27) had a medium‐high risk of bias. Few high‐quality studies address HNC survivorship. Future rigorously designed studies should address broader care areas, including chronic disease management and health promotion/disease prevention.
Like
Save
Share